Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cogstate Ltd ( (AU:CGS) ) has issued an announcement.
Cogstate Ltd has announced the final notification of its on-market buy-back program, with a total of 5,870,804 ordinary fully paid securities repurchased for a consideration of AUD 7,646,946.04. This buy-back is part of the company’s strategy to optimize its capital structure, potentially enhancing shareholder value and reflecting confidence in its financial position.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, primarily focusing on cognitive science and technology. The company provides digital cognitive assessment tools and services, catering to clinical trials, academic research, and healthcare markets.
YTD Price Performance: 161.37%
Average Trading Volume: 252,584
Technical Sentiment Signal: Buy
Current Market Cap: A$463.4M
Learn more about CGS stock on TipRanks’ Stock Analysis page.